Melanotan I Reference

Melanocortin agonist (alpha-MSH analog) · Approved as an implant (Scenesse, for EPP); research compound as an injectable solution

ClassMelanocortin agonist (alpha-MSH analog)
StatusApproved as an implant (Scenesse, for EPP); research compound as an injectable solution
Typical vials10 mg
Dose range0.25 mg to 1 mg
FrequencyDaily to a few times weekly, in loading then maintenance phases
Half-lifeNo human data
Dosing unitmilligrams
RouteSubcutaneous injection

What Melanotan I is

Melanotan I is the linear alpha-MSH analog that became the approved drug afamelanotide (Scenesse), an implant that protects people with erythropoietic protoporphyria by driving protective skin pigmentation. The gray market sells the same peptide as a reconstitutable vial for cosmetic tanning. It is the better-mannered sibling of Melanotan II: more selective for the pigmentation receptor, without MT-II's libido and nausea side effects, but also slower to show results.

Reconstitution math

Concentration is everything: the same 10 mg vial gives a different draw for every amount of bacteriostatic water you add. The table uses the common 2 mL setup for each vial size, which puts every unit on a U-100 insulin syringe at 50 mcg for the default vial. Dashes mark draws too small to measure or larger than the syringe.

VialBAC waterConcentration0.25 mg0.5 mg1 mg
10 mg2 mL5 mg/mL5 u10 u20 u
Melanotan I syringe drawsDRAW GUIDEEach dose as a filled syringe10 mg vial + 2 mL bacteriostatic water = 0.5 mg per 0.1 mL (10 units).02468101214161820units on a U-100 insulin syringe (first 20 units shown)0.25 mg5 u (0.05 mL)0.5 mg10 u (0.1 mL)1 mg20 u (0.2 mL)peprecon.com
Draw positions for the common doses at the default setup.

Dosing and protocol

Community tanning protocol: 0.25 to 1 mg per injection, daily during loading, then once or twice weekly for maintenance.

Community tanning protocols load at 0.25 to 1 mg daily alongside modest UV exposure until the target shade develops, then drop to once or twice weekly maintenance. On a 10 mg vial with 2 mL of water, 0.5 mg is a 10-unit draw. Sunscreen discipline still applies; the peptide darkens skin but does not confer the full protection of melanin developed under medical supervision.

Pharmacokinetics

No curve is shown, on purpose.

The approved form is a 16 mg subcutaneous implant that releases over days, and its published kinetics describe the implant, not a reconstituted solution injection. No pharmacokinetic profile exists for the gray-market solution form, so the implant data cannot be honestly re-plotted here.

Storage and handling

Lyophilized vials keep best cold, dark, and dry; refrigeration is the community default and freezing lyophilized powder is common for long holds. After reconstitution, refrigerate at 2 to 8 C, do not freeze the solution, and date the vial. Bacteriostatic water's preservative keeps multi-dose use practical for about 28 days by USP convention, though our 120-day stability study found the preservative itself outlasts that window.

Got a certificate of analysis with your vial? Run it through our COA Reader: it reads the report in plain English, checks purity and mass against the label claim, and links the testing lab’s own verification page. Our guide to reading a COA explains what the numbers do and do not tell you.

Sources

  1. Scenesse (afamelanotide) prescribing information (Clinuvel)
  2. Minder et al., Afamelanotide, an agonistic analog of alpha-MSH, in dermatology, Expert Opin Investig Drugs 2017

Related references: KPV